Abstract
Objective: Previous studies reported a poor outcome in patients with coronavirus 2019 (COVID-19) undergoing cardiac surgery. Complications most frequently described were respiratory failure, renal failure, and thromboembolic events. In their recent experience, the authors observed a very high incidence of bleeding complications. The purpose of the study was to investigate a possible significant correlation between perioperative COVID-19 infection and hemorrhagic complications compared to non-COVID-19 patients.
Design: Single-center, observational, retrospective, matched case-control (1:2) study involving patients who underwent open-heart cardiac surgery from February 2020 and March 2021 with positive perioperative diagnosis of COVID-19 infection, matched with patients without COVID-19 infection.
Setting: Cardiac surgery unit and intensive care unit of a university tertiary center in a metropolitan area.
Participants: In the study period, 773 patients underwent cardiac surgery on cardiopulmonary bypass (CPB). Among them, 23 consecutive patients had perioperative diagnosis of COVID-19 infection (study group). These patients were compared with 46 corresponding controls (control group) that matched for age, sex, body mass index, and Society of Thoracic Surgeons score.
Interventions: Open-heart cardiac surgery on CPB.
Measurements and main results: In the study group, 2 patients (9%) died in the intensive care unit from severe respiratory failure, shock, and multiple organ failure. In the study group, patients showed a significantly higher incidence of bleeding complications (48% v 2%, p = 0.0001) and cases of surgical reexploration for bleeding (35% v 2%, p = 0.0001), a higher incidence of severe postoperative thrombocytopenia (39% v 6%, p = 0.0007), and a higher need of blood components transfusions (74% v 30%, p = 0.0006). Chest tubes blood loss and surgical hemostasis time were markedly prolonged (p = 0.02 and p = 0.003, respectively).
Conclusions: A worrisome increased risk of early and late bleeding complications in COVID-19 patients was observed, and it should be considered when assessing the operative risk. CPB-related inflammatory reaction could exacerbate the deleterious effect of COVID-19 on the coagulation system and likely deviate it toward a hemorrhagic pattern.
Keywords: COVID-19; bleeding; cardiac surgery; cardiopulmonary bypass; coronavirus; intensive care unit.
【저자키워드】 COVID-19, coronavirus, bleeding, intensive care unit., Cardiac surgery, cardiopulmonary bypass, 【초록키워드】 Respiratory failure, intensive care, severe respiratory failure, Infection, Cardiopulmonary, Sex, surgical, outcome, Hemostasis, Shock, body mass index, COVID-19 infection, Patient, Control, Complication, Case-control, complications, age, Coagulation system, incidence, Coronavirus 2019, multiple organ failure, correlation, Blood, retrospective, cardiac, Deleterious, COVID-19 patient, Hemorrhagic, Society, Thromboembolic events, Non-COVID-19 patients, control group, study group, increased risk, study period, inflammatory reaction, previous study, renal, positive, measurement, chest tube, described, died, reported, postoperative, significantly higher, exacerbate, blood component, consecutive patient, deviate, diagnosis of COVID-19, operative risk, patients without COVID-19, the study group, 【제목키워드】 Complication, cardiac, Perioperative, Matched,